PSTV
NASDAQ
$3.83
Plus Therapeutics Inc (PSTV)
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing, and commercialization of treatments for patients with cancer and other diseases. The company is headquartered in Austin, Texas.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $36 (+839.95%)
Market Cap
$28M
Free Cash Flow Yield
-77.59%
Price Chart
Valuation
Market Cap$28M
Forward P/E0.97
PEG2.45
P/S5.42
P/B2.48
Profitability
Total Revenue (TTM)$5.18M
Gross Profit (TTM)-$4.31M
EBITDA-$18M
Profit Margin-230.2%
Operating Margin-693%
EPS-$1.49
Financial Health
Free Cash Flow Yield-77.59%
Growth & Risk
EPS 5Y CAGR-25.42%
FCF 5Y CAGR+16.76%
Sharpe Ratio-0.10